IDM Building Cell Manufacturing Network For Phase III Cancer Trial
Executive Summary
Immuno Designed Molecules is building a network of cell processing centers for local preparation of its ovarian cancer cell therapy, CEO Jean-Loup Romet-Lemonne told the Ernst & Young/Atlas Venture Eighth European Life Sciences Conference April 17 in Amsterdam.